LAST: PREVENTION AND TREATMENT - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

LAST: PREVENTION AND TREATMENT

Description:

LAST: PREVENTION AND TREATMENT ... Esters Eg: Procaine, Cocaine, tetracaine The ester linkage is cleaved by plasma cholinesterase. Short half life( abt 1min). – PowerPoint PPT presentation

Number of Views:61
Avg rating:3.0/5.0
Slides: 21
Provided by: BENA165
Category:

less

Transcript and Presenter's Notes

Title: LAST: PREVENTION AND TREATMENT


1
LAST PREVENTION AND TREATMENT
  • PART A

2
PART A OVERVIEW
  • What are local anesthetics
  • Classification
  • MOA
  • Anesthetic potency
  • Clearance
  • Uses
  • Prolongation of action

3
PART B ADVERSE EFFECTSSYSTEMIC TOXICITY
  • Allergic reaction
  • Local toxicity
  • Systemic toxicity

4
What are LA
  • Weak bases which produce a transient and
    reversible loss of sensation (analgesia) in a
    circumscribed region of the body without loss of
    consciousness.
  • Normally, the process is completely reversible.

5
Classification
  • Local anesthetics - esters or amides.
  • Major difference is their potential for producing
    adverse effects and the mechanisms of their
    metabolism.

6
Esters
  • Eg Procaine, Cocaine, tetracaine
  • The ester linkage is cleaved by plasma
    cholinesterase. Short half life( abt 1min).
  • Amides
  • Eg lidocaine, Marcaine(Bupivacaine),
    ropivacaine. Amide linkage is cleaved in the
    liver. Half life is about 2-3 hrs

7
MECHANISM OF ACTION
  • LA block nerve conduction by impairing
    propagation of action potential in axons.
    Interact directly with Na channels and stop Na
    ion influx. May also act on K Ca channels.
  • LA need to diffuse passively in uncharged state
    (lipophilic) to reach target-axoplasmic side of
    Na channel.

8
(No Transcript)
9
HOW MUCH IS TOO MUCH?
ESTERS MAX DOSE(mg/kg) DURATION (HOURS)
Chloroprocaine 12 0.5 1
Procaine 12 0.5 1
Cocaine 3 0.5 1
Tetracaine 3 1.5 6
10
Amides Max Dose (mg/kg) Duration (h)
Lidocaine 4.5/(7 with epi) 0.75 1.5
Mepivacaine 4.5/(7 with epi) 1 2
Prilocaine 8 0.5 1
Bupivacaine 3 1.5 8
Ropivacaine 3 1.5 8
11
ANESTHETIC POTENCY
  • The more LA is lipophilic the more potent it is (
    increased rate of diffusion).
  • More protein binding prolongs the effect.
    Bupivacaine is approximately 95 protein-bound.
  • Intermediate-duration LAs (lidocaine and
    mepivacaine) have a smaller protein-bound
    fraction (60-70).
  • pH higher pH speeds action (keeps LA uncharged).
  • pKa lower pKa faster onset.
  • Concentration higher conc. rapid onset (mass
    effect).

12
CLEARANCE
  • ESTERShydrolysis via tissue cholinesterase
  • AMIDESmetabolism via hepatic enzymes

13
USES
  • Surface anesthesia
  • Infiltration anesthesia
  • Regional anesthesia

14
SURFACE ANESTHESIA
  • On intact skin
  • eutectic mixture of
  • Local anesthetics
  • (EMLA)
  • Slow absorption,
  • Action up to ½ Hr

15
INFILTRATION ANESTHESIA
  • LA infiltrates locally into tissues to numb the
    area.
  • Purpose of pain free procedures-before injections
    with large needles, lumbar puncture

16
REGIONAL ANESTHESIA
  • Nerve block
  • Intravenous
  • Epidural/Extradural
  • Intrathecal block/ spinal anaesthesia

17
NERVE BLOCKS
  • Inject a drug around the nerve
  • Anaesthetise a region

18
INTRAVENOUS ANESTHESIA
  • 0.5-1 lidocaine without adrenaline
  • Biers Block

19
EPIDURAL
  • Thoracic, lumbar, sacral
  • Act on nerve roots
  • Less hypotention

20
SPINAL BLOCK
  • Sympathetic nerve block
  • hypotension
Write a Comment
User Comments (0)
About PowerShow.com